RAPT Therapeutics, Inc.
RAPT Therapeutics, Inc.（RAPT）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
rapt · 股价预测 · 15 位分析师（近3月）· FMP · 更新于 2026年3月26日
分析师评级与共识
基于过去 3 个月内 15 位华尔街分析师
Hold
15 位分析师
共识
评级分布
12 个月目标价
High
$58.00
Consensus
$58.00
-0.0% upside
Low
$58.00
Median: $58 · Last Close: $58.01
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $57.90 | ↓ 0.20% |
1-day model range: $57.89–$57.91. Peak: $57.91 (-0.20%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · RAPT · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-01-21 | Leerink Partners | Downgrade ↓ | Outperform→Market Perform |
| 2026-01-21 | Barclays | Downgrade ↓ | Overweight→Equal Weight |
| 2026-01-20 | TD Cowen | Downgrade ↓ | Buy→Hold |
| 2026-01-20 | Clear Street | Downgrade ↓ | Buy→Hold |
| 2026-01-20 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2026-01-20 | Wells Fargo | Downgrade ↓ | Overweight→Equal Weight |
| 2026-01-20 | LifeSci Capital | Downgrade ↓ | Outperform→Market Perform |
| 2025-11-12 | JP Morgan | Maintains | Overweight→Overweight |
| 2025-11-07 | Barclays | Maintains | Overweight→Overweight |
| 2025-11-03 | Wells Fargo | Maintains | Overweight→Overweight |
Wall Street analysts have recently issued updated ratings on RAPT Therapeutics, Inc. (RAPT) stock. Of the recent 65 rating actions, 4 were upgrades and 16 were downgrades. 15 analysts currently cover RAPT.
分析师推荐趋势
RAPT analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$1M
↓ 4.6% YoY
Revenue Next Year
$10M
↑ 1226.1% YoY
EPS This Year
$-2.40
EPS Next Year
$-3.17
↑ 32.1% YoY
EPS ForecastReported vs Estimated
Analysts forecast RAPT EPS of $-2.40 for the current fiscal year, based on estimates from 4 analysts. The RAPT revenue forecast is $1M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
RAPT 股价预测由两类独立数据源支撑：来自 15 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。RAPT 的共识目标价为 $58.00（-0.0% 上行空间），分析师共识为 Hold。
RAPT 的短期预测（明日）为 $57.90（-0.20%）。
RAPT Therapeutics, Inc. 在 NASDAQ 上市，代码 RAPT。RAPT 在 2027 年的整体展望偏中性/分化，在覆盖分析师中约 27% 对应 Hold 共识。
常见问题
RAPT 预测 · 8 个问题根据 15 位华尔街分析师，RAPT 的 12 个月平均目标价为 $58.00，最高 $58.00、最低 $58.00。若有图表，中位目标价可在上方查看。相对当前价 $58.01，隐含约 -0.0% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.